Navigation Links
Spectral announces 2007 financial results
Date:3/7/2008

g capital (59) (664)

-------------------------

(732) (1,059)

-------------------------

Investing activities

Purchase of property, plant and equipment (280) (157)

Purchase of technology and trademarks (44) (22)

Purchase of commercial instruments (173) (113)

Decrease (increase) in short-term investments 768 (1,707)

Deferred revenue 150 -

-------------------------

421 (1,999)

-------------------------

Financing activities

Issuance of common shares 4 -

-------------------------

Decrease in cash and cash equivalents

during the period (307) (3,058)

Cash and cash equivalents

- Beginning of period 945 4,003

-------------------------

Cash and cash equivalents - End of period 638 945

-------------------------

-------------------------

Non-cash investing and financing activities

Settlement of existing convertible

notes payable - (9,801)

Issuance of new convertible note payable - 1,761

Issuance of common shares on settlement'/>"/>

SOURCE Spectral Diagnostics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
2. US Patent and Trademark Office Allows CRis Patent Application for Spectral Imaging of Deep Tissue
3. CRi Announces Nuance 2, the Next-Generation Multispectral Imaging System for Brightfield and Fluorescent-Based Microscopy
4. Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
5. Spectral appoints Anthony Bihl to Board of Directors
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... ALTO, Calif. , May 17, 2013 /PRNewswire/ ... it has achieved 50% enrollment of the total ... to evaluate the safety and preliminary efficacy of ... Cells) therapy for Knee Osteoarthritis (KOA). To date ... (SAE) reported. The Phase I open ...
(Date:5/17/2013)... -- Insero Health, Inc., a company developing natural compounds to ... disorders, is today reporting top-line results from a Phase ... with drug-resistant epilepsy.  The data are being presented at ... by Dr. Steven Schachter , Harvard ... Board.  In this study, INS001 appeared safe and well ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 RURO ... ezColony version 4.1, a versatile refinement to the ... software solution, improves its advanced methodical management for ... with ezColony 4.1. The network-based platform provides user ... effective research. While continuing to emphasize streamlined tasks, ...
(Date:5/17/2013)... 2013 Tooth decay is an epidemic in ... of the disease. The World Health Organization says that worldwide, ... adults have cavities. What are the long-term effects of this ... strong connection between the oral bacterial imbalance and serious systemic ... rampant, yet it is also 100% preventable? Answer: there has ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... ... $20 million in yearly revenues and have experienced significant growth over the last 12 months. ... ... Orange County has become a hub for innovation and growth and Southern California Venture Network ...
... , Hopkinton, Mass., Sept. 24 Caliper Life ... tools and services for drug discovery and life sciences research, today ... World Molecular Imaging Congress (WMIC) in Montreal, Canada. Rediject D-Luciferin Ultra ... Caliper,s IVIS optical imaging systems. , , ...
... , , SALT LAKE CITY, ... care through the development of molecular diagnostics, announced today that ... to spine specialists in the United States. SCOLISCORE is a ... of scoliosis, an abnormal lateral curvature of the spine. Spine ...
Cached Biology Technology:Southern California Venture Network to Recognize Local Companies At 2009 Emerging Growth Awards 2Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 2Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 3Axial Biotech Announces Commercial Availability of SCOLISCORE(TM) AIS Prognostic Test 2Axial Biotech Announces Commercial Availability of SCOLISCORE(TM) AIS Prognostic Test 3
(Date:5/18/2013)... (May 18, 2013) Research presented today at Digestive ... research, with findings about the impact of coffee on ... , While coffee consumption recently has been associated with ... even a few more cups of java each month ... liver disease. Researchers at the Mayo Clinic, Rochester, MN, ...
(Date:5/18/2013)... Research presented at Digestive Disease Week (DDW) ... diet and lifestyle. , Individuals suffering from ... strength, fatigue and poor quality of life. These ... remission. A randomized, double blind, placebo-controlled study found ... corresponded to significant relief of these symptoms. ...
(Date:5/18/2013)... 2013) An increasing number of U.S. children ... resolve, according to research presented at Digestive Disease ... obesity, researchers at the Cleveland Clinic Children,s Hospital ... of exhaled breath compared to their lean counterparts. ... levels that can be correlated to potential complications ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3
... threat to the healthy growth of coral reefs in ... could one day treat human diseases, a new study ... UC San Diego has revealed. An analysis led ... laboratory at Scripps, has shown that the seaweed, a ...
... , Athens, Ga. Human breast milk is the best ... found what may be a new second bestformula made from ... professor of food science and technology in the College of ... hazelnut oil that better mimics the structure of mother,s milk, ...
... is available in German . In the ... sometimes, it is the most beautiful. A well-known example is the ... fan. A research team at Bielefeld University headed by the evolutionary ... mechanism is involved in mate choice among locusts. The male Siberian ...
Cached Biology News:Nuisance seaweed found to produce compounds with biomedical potential 2Hazelnuts improve infant formula 2A mating dance with Popeye arms 2
Rabbit polyclonal to ErbB 2 ( Abpromise for all tested applications). entrezGeneID: 2064 SwissProtID: P04626...
Anti-CoralHue Dronpa Green Monoclonal Antibody Research Focus: cell surface antigens Storage: -20C Shipping Temperature: +4C...
Phospho-FKHR (Thr24)/FKHRL1 (Thr32) Antibody...
Prostaglandin-E2 receptor EP2/EP3 Market Segment: GPCRs...
Biology Products: